Related Experiment Video

Updated: Oct 26, 2025

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica
03:32

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica

Published on: April 12, 2019

8.1K

[Severe chemical pneumonitis secondary to talc inhalation. A pediatric case]

Agustina Teves Echazú1, Javier Fain2, Rodolfo P Moreno2

  • 1Servicio de Pediatría, Sanatorio de la Trinidad Palermo, Ciudad Autónoma de Buenos Aires, Argentina. agustinatevesechazu@gmail.com.

Archivos Argentinos De Pediatria
|July 26, 2021
PubMed

Insights

Accidental talcum powder inhalation in children can cause severe respiratory distress. This case highlights the dangers of talc pneumonitis and the need for prompt medical intervention in pediatric respiratory emergencies.

Area of Science:

  • Pediatric Pulmonology
  • Toxicology
  • Emergency Medicine

Background:

  • Talc, a hydrated magnesium silicate, has been traditionally used in infant care.
  • Accidental talcum powder inhalation in children, though infrequent, poses significant respiratory risks.
  • Potential complications include severe respiratory distress and mortality.

Observation:

  • A 14-month-old child experienced accidental talc inhalation during a diaper change.
  • The child developed chemical pneumonitis and acute respiratory distress syndrome (ARDS).
  • Mechanical ventilation was required for one week due to severe respiratory compromise.

Findings:

  • The patient received systemic antibiotics, corticosteroids, and aerosol therapy.
  • No other organ system complications were noted.
  • Hospitalization lasted ten days, with follow-up revealing isolated bronchial hyperresponsiveness.

Implications:

  • This case underscores the critical dangers of talcum powder aspiration in young children.
  • It emphasizes the need for cautious use of talc-based powders around infants.
  • Highlights the importance of aggressive respiratory support and management in pediatric talc pneumonitis.

Keywords:
inhalationpneumonia aspirationtalc

More Related Videos

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

1.0K
An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing09:29

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

Published on: May 13, 2020

11.9K

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
503
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
646
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
427
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
706
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.0K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.1K